Seventeen neglected tropical diseases (NTDs) have been identified by the World Health Organization (WHO). It is estimated that over 1 billion people are infected with NTDs, with a further 1 billion at risk. The majority of NTDs occur in the tropics and sub-tropics and have particular characteristics in common:
• They afflict the poorest people -those without access to the safe water, sanitation, and basic health services required in order to protect themselves against infection by bacteria, viruses and other pathogens. High-income groups are rarely affected.
• Many are chronic, slowly developing conditions that become progressively worse if undetected and untreated. The damage they cause can be irreversible.
• They can cause severe pain and life-long disabilities, with long-term consequences for the person and also for family members who have to care for the person.
• People with NTDs are often stigmatised and excluded from society, and this can affect their mental health.
The individual diseases are very different, and one person can be affected by more than one disease at the same time.
The infectious agents responsible include:
• viruses (rabies and dengue)
• bacteria (leprosy, yaws, trachoma and Buruli ulcer) • protozoa (leishmaniasis and trypanosomiasis) • helminth parasites (schistosomiasis, lymphatic filariasis, onchocerciasis, intestinal worms and Guinea worm).
Transmission is equally diverse and can take place via:
• flies, fomites (e.g. skin cells, hair, clothing or bedding) and fingers (trachoma)
• mosquitoes (dengue fever and filariasis)
• tsetse flies (sleeping sickness)
• sandflies (leishmaniasis)
• blackflies (onchocerciasis)
• snails, which release infective larvae into water to penetrate human skin (e.g schistosomiasis) • the faeco-oral route (e.g. soil-transmitted helminths -see page 29) or via food products.
NTDs can cause blindness (onchocerciasis and trachoma), deformity and disablement, disfigurement, cancers, and neurological problems.
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In 1988, Merck in the USA made Mectizan available at no cost to communities with onchocerciasis infection. The commitment was 'as much as is needed for as long as it is needed.' This game-changing donation heralded the development of a new global partnership in health between the pharmaceutical industry, UN agencies, national ministries of health, non-governmental organisations and communities at risk -sectors of society which normally do not work together. Although they have different structures, driving forces, and skills, they agreed to break down the barriers that usually make them work in separate silos and to come together with a common vision to control and eliminate the specific diseases affecting neglected people. Two of these diseases -onchocerciasis and trachoma -cause blindness. Thanks to these ongoing donations, the challenge with neglected tropical diseases today is not so much to discover a treatment but rather to reach the very remote communities with an integrated, effective and sustainable programme of disease control.
This edition of the Journal aims to inform our readers about the neglected tropical diseases, the communities affected, and the available control measures. Emphasis is placed on integration and learning from each other to make the programmes more effective.
About this issue
The biological diversity of NTDs means that the control or elimination strategies also are very diverse.
Several NTDs can be controlled by drug treatment (preventive chemotherapy), on a country or community scale, via mass drug administration programmes. Other NTDs require different approaches and strategies for control or elimination, including specialised drugs and/or vector control (limiting or eradicating insectse.g. fl ies and bugs -that transmit the pathogens).
Despite the diversity of the strategies, however, there are good opportunities for comprehensive NTD elimination and control programmes.
the social and economic impact of NtDs
NTDs are a result of poverty; they also contribute to further poverty in those people affected. Indeed, the prevalence of some NTDs has been suggested as an indicator of poverty.
1,2 They also have a wide social and economic impact:
• the loss of ability to undertake traditional farming practices, critical for survival in rural environments • the loss of ability to play an economic and social role within the family and community • the cost of inappropriate treatment (for example, traditional healers), which enhances the cycle of poor health and poverty • the loss of educational opportunities, as children must act as caregivers for their parents, creating a generation of people with little or no education • poor mental health of the patient and the caregiver, particularly chronic depression. 
Neglected tropical diseases
What are the neglected tropical diseases?
• flies, fomites (e.g. skin cells, hair, clothing or bedding) and fingers (trachoma) • mosquitoes (dengue fever and filariasis)
• tsetse flies (sleeping sickness) • sandflies (leishmaniasis) • blackflies (onchocerciasis) • snails, which release infective larvae into water to penetrate human skin (e.g schistosomiasis) • the faeco-oral route (e.g. soil-transmitted helminths -see page 29) or via food products.
NTDs can cause blindness (onchocerciasis and trachoma), deformity and disablement, disfigurement, cancers, and neurological problems. In 1988, Merck in the USA made Mectizan available at no cost to communities with onchocerciasis infection. The commitment was 'as much as is needed for as long as it is needed.' This game-changing donation heralded the development of a new global partnership in health between the pharmaceutical industry, UN agencies, national ministries of heath, non-governmental organisations and communities at risk -sectors of society which normally do not work together. Although they have different structures, driving forces, and skills, they agreed to break down the barriers that usually make them work in separate silos and to come together with a common vision to control and eliminate the specific diseases affecting neglected people. Two of these diseases -onchocerciasis and trachoma -cause blindness. Thanks to these ongoing donations, the challenge with neglected tropical diseases today is not so much to discover a treatment but rather to reach the very remote communities with an integrated, effective and sustainable programme of disease control.
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What is being done to control NtDs?
The drugs needed to treat NTDs are now included on the WHO 'Essential Medicines' list, and pharmaceutical companies are making them freely available to the populations in need through donation programmes.
These programmes, together with increased country commitment to the control of NTDs and novel approaches to drug distribution (e.g. through community-directed interventions or school health programmes) have made it possible to address some NTDs (trachoma, onchocerciasis, lymphatic filariasis, soil-transmitted helminths, and schistosomiasis) on a massive scale, in what have become known as mass drug administration (MDA) programmes.
Community-directed treatment has been developed and promoted as a recommended way of providing mass drug administration. Communities take responsibility for the collection, delivery, and reporting of drug use. This is an effective approach: annual treatment records for onchocerciasis suggest that some 70% of the ivermectin approved for use is administered to those who need it within a 12-month period.
Mass drug administration programmes bring multiple benefits, including:
• direct impact on individual health, even beyond the target infection • improved community engagement in health programmes • better access to health care for populations that had little or no access • an improved drug supply chain • enhanced data management, monitoring, evaluation, surveillance and reporting systems.
What more needs to be done?
The majority of countries in Africa have completed their NTD master plans.
Resources must be allocated to these plans and countries need to commit to the World Health Assembly (WHA) Resolution 5 and the WHO Road Map. 6 The second WHO Report on NTDs, 'Sustaining the Momentum' 7 , was published recently and identified progress since the first report.
8 It also identifies the challenges in the way of achieving the disease-specific goals.
There is a need for rapid up-scaling in some of the most populous countries to reach the WHO targets and timelines for control/elimination. To address this, NTD partners need to:
• engage in advocacy in their country • complete mapping • enhance human resource capacity in order to deliver integrated treatments within the health system • address the backlog of surgery for some diseases (in particular, trachoma and lymphatic filariasis)
• implement a new strategy in areas where Loa loa (tropical eye worm) is co-endemic with lymphatic filariasis. This is due to the problems of severe reactions to ivermectin when people have high parasite loads of Loa loa.
Globally, the investment required for the delivery of donated drugs is estimated at around US $0.50 per person treated, per year. Included in this 'unit cost' is the cost of training, social mobilisation, evaluation and monitoring, and surveillance, all of which are needed for mass drug administration programmes to be effective. The unit cost is estimated to be even lower in some settings: around US $0.10 -0.20 per person treated, per year. Even in the poorest countries, this represents just a small fraction of the national per capita health expenditure.
Conclusion
Programmes to eliminate and control NTDs address issues of equity (equal access to health care) and are interventions that directly benefit the poor. The
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• On 27th May 2013, the WHA passed a resolution on all 17 neglected tropical diseases (Resolution WHA 66.20). Action on neglected tropical diseases at the global level Nigeria. Ibadan is an ancient city that grew around its traditional palace. Out of the city's overcrowded and labyrinthine streets, weeping mothers streamed daily to the tertiary teaching hospital less than half an hour away with children dying or dead from diseases such as malaria, diarrhoea, or marasmus. In the hospital, they saw clean wards with crisp white bed sheets -an unimaginable and unattainable luxury for them in their homes. Meanwhile, medical students ventured in the opposite direction, through the same labyrinthine depths and into homes in which gutters with filthy waste water ran through the middle of rooms and the latrine was just outside the window. Their purpose? A paediatric posting, but the challenges they found in these urban slums demanded a public health approach. Their traditional doctor's training was powerless in the face of such challenges.
Nairobi, Kenya. Known as a cantankerous old woman, she lived alone in a large house in the expensive part of town. The house and garden had seen better days. Someone came in to drop her daily meal and rushed out because of the strong smell of decay and the madness of the old woman. When she was found unable to walk because of a fall in her kitchen and forced to go to the clinic, it was discovered that she had blinding cataracts; her poor vision at least one of the causes of her apparent self-neglect. She epitomised neglect by self and by others -even in the absence of poverty.
Like the people in Tunku and in the slums around Ibadan, poor and/or remote communities around the world -whether rural or urban -are often neglected, whether in Africa, the Amazon, Australia or the Indian sub-continent. However, neglected people can even be found in affluent communities.
If we want to address neglected tropical diseases (NTDs), we have to focus on the communities affected. As David Molineux writes on pages 21-24, NTDs affect people who are neglected in a variety of ways: through poverty and lack of access to basic water and sanitation, health services, and education ... In fact, just about every facet of development.
How can eye care programmes respond to the challenge of reaching these neglected people? Here are some examples of different strategies.
sri Lanka: into every home Midwives, who function as family health workers, form the backbone of health service delivery in Sri Lanka. In 2000, there were over 5,000 midwives in the country, each responsible for between 3,000 and 4,000 people. This network should -in theory -reach the entire population of Sri Lanka. In rural Sri Lanka, it was noted at a Sightsavers review of primary eye care in 2010, that the midwives are welcomed into people's homes and know every household and family member intimately: the child whose Road to Health chart is kept by his literate mother (Sri Lanka has a 98% literacy rate), the grandfather with hypertension, and the grandmother reluctant to wear her glasses. One even helped a father who was determined to
NeGLeCteD CoMMuNities
Neglected communities drug treatments are effective and broadly safe when correct policies are followed (see page 26).
Mass drug administration programmes that reduce morbidity, mortality and transmission -leading to elimination of some of the world's most distressing diseasesshould be regarded as akin to global immunisation when viewed from a strategic perspective. They have proved that it is possible to deliver free drugs to the poorest in need at unit costs that even some of the poorest countries can afford, and have already afforded. We must call for this successful intervention to be made available to everyone who needs treatment. If this relatively easy type of intervention -free drugs, no need for a cold chain -cannot be replicated and scaled up to reach everyone who needs treatment, worldwide, there is little hope that we can make a signifi cant impact in other priority areas, such as maternal and child health, or vaccinations.
The NTD community has been successful in achieving a paradigm shift in the global health community's thinking about these diseases, as exemplifi ed in a WHA Resolution and their inclusion in the a post-2015 Health Goal (see panel, page 23). What were hitherto unpronounceable conditions of poor people, and which did not concern high-income countries, are now high on the global health agenda. Consciousness has been raised but there remain many challenges, both technical and operational.
A higher level of commitment is needed from the endemic countries, additional donors, non-governmental organisations, and charities. NTD partnerships recognise that they must face the following challenges: communicating the need for country commitment to enhance geographic and therapeutic coverage and improve compliance, and achieving this by prioritising capacity strengthening from the centre to the communities. What kinds of neglected communities are out there?
'NTDs affect people who are neglected in every facet of development'
